BLINCYTO 38.5 micrograms, powder for solution for dilution and solution for infusion bottle, 10 ml
Active ingredients: Blinatumomab
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for dilution and solution for infusionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BLINCYTO 38,5 microgrammes, poudre pour solution à diluer et solution pour solution pour perfusion
- Pharmaceutical form
- poudre à diluer à diluer et solution pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 2016
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62003633CIP75501347CIP133400955013471Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BLINATUMOMABpoudre | 38,5 microgrammes · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.